GenScript Starts Construction of Cell Therapy and Antibody Manufacturing Facility Apr 16, 2019 Life Science
BioSense Acquires China Rights to Rexahn’s Pancreatic Cancer Drug in $226 Million Deal Apr 16, 2019 Life Science
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies Apr 16, 2019 Life Science
Catalent Buys Paragon for $1.2 Billion to Build its Gene Therapy Vector Capabilities Apr 15, 2019 Life Science
Creative Bio of Guangzhou Raises $45 Million for Early Colorectal Cancer Test Apr 12, 2019 Life Science
Cullgen Receives $16 Million Series A Investment to Advance Pipeline of Targeted Protein Degraders Apr 10, 2019 Life Science
Shanghai Miracogen Signs $125 Million Deal to Use Synaffix ADC Technologies Apr 10, 2019 Life Science
Eastwood Bio-Medical Canada Provides Further Information Respecting Revenue Increases Apr 10, 2019 Life Science
